SCHEMBL6558564

SCHEMBL6558564

O=C(Cn1ncnn1)c1ccc(Cl)cc1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ HIF1A Q16665 1/20 0.53
▸ P2RX7 Q99572 3/20 0.48
▸ ERCC5 P28715 2/20 0.48
▸ FEN1 P39748 2/20 0.48
▸ MAPT P10636 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ POLB P06746 2/20 0.47
▸ TSHR P16473 2/20 0.45
▸ CASP1 P29466 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ LMNA P02545 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ PAX8 Q06710 1/20 0.42
▸ KLF5 Q13887 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29025711 0.86 POLB (0.45) ALDH1A1MAPK1HIF1AP2RX7ERCC5
SCHEMBL30356468 0.84 POLB (0.58) ALDH1A1ERCC5FEN1MAPTKDM4E
SCHEMBL1682664 0.84 POLB (0.58) ALDH1A1ERCC5FEN1MAPTKDM4E
SCHEMBL16411136 0.81 ALDH1A1 (0.59) ALDH1A1MAPK1HIF1AP2RX7ERCC5
SCHEMBL30356525 0.81 POLB (0.46) ALDH1A1MAPK1HIF1AP2RX7MAPT
SCHEMBL6556649 0.80 MAPT (0.48) ALDH1A1P2RX7ERCC5FEN1MAPT
SCHEMBL30356530 0.80 POLB (0.42) ALDH1A1MAPK1HIF1AP2RX7MAPT
SCHEMBL29025627 0.80 POLB (0.42) ALDH1A1MAPK1HIF1AP2RX7MAPT
SCHEMBL30356535 0.79 POLB (0.46) ALDH1A1MAPTKDM4EPOLBSMN1; SMN2
SCHEMBL29025637 0.79 POLB (0.46) ALDH1A1MAPTKDM4EPOLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1003505-B1 HETEROCYCLIC VINYLETHERS AGAINST NEUROLOGICAL DISORDERS HOFFMANN LA ROCHE (CH) 2004-03-24 — — EP disclosed
US-6248901-B1 (1-PHENYL-2-CYCLOALKYLOXY-VINYL)-(1,2,4)TRIAZOLES; CONTROL OR PREVENTION OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS. HOFFMAN-LA ROCHE INC. 2001-06-19 — — US disclosed
EP-1003505-A1 HETEROCYCLIC VINYLETHERS AGAINST NEUROLOGICAL DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2000-05-31 — — EP disclosed
US-6054588-A Heterocyclic vinyl ethers HOFFMAN-LA ROCHE INC. (US) 2000-04-25 — — US disclosed
WO-1999008678-A1 HETEROCYCLIC VINYLETHERS AGAINST NEUROLOGICAL DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 1999-02-25 — — WO disclosed
Send feedback